Home
PODD
PODD News

Latest Insulet Corporation (PODD) News on November 17, 2024

Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals

Simply Wall St.

a day ago

Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals

Insulet to Present at Upcoming Investor Conferences

Business Wire

2 days ago

Insulet to Present at Upcoming Investor Conferences

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

4 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks.com featured highlights include NVIDIA, Insulet and Howmet Aerospace

Zacks

4 days ago

Zacks.com featured highlights include NVIDIA, Insulet and Howmet Aerospace

Argus Research

5 days ago

PODD: Raising target price to $289.00

Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More

Zacks

5 days ago

Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Zacks

5 days ago

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up

Zacks

5 days ago

PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up

Insulet price target raised to $317 from $234 at Morgan Stanley

TipRanks

5 days ago

Insulet price target raised to $317 from $234 at Morgan Stanley

MT Newswires

6 days ago

Barclays Adjusts Price Target on Insulet to $234 From $220, Maintains Equalweight Rating

Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts

Simply Wall St.

7 days ago

Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts

Insulet Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

8 days ago

Insulet Third Quarter 2024 Earnings: Beats Expectations

S&P 500 Gains and Losses Today: Axon Shares Surge as Taser Maker Tops Estimates

Investopedia

9 days ago

S&P 500 Gains and Losses Today: Axon Shares Surge as Taser Maker Tops Estimates

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues

Investor's Business Daily

9 days ago

Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High

Investor's Business Daily

9 days ago

Costco Stock Breaks Out Past Buy Point, Reaches All-Time High

MT Newswires

9 days ago

Wolfe Research Adjusts Price Target on Insulet to $265 From $220

MT Newswires

9 days ago

Leerink Partners Adjusts Price Target on Insulet to $278 From $262

MT Newswires

9 days ago

Jefferies Raises Price Target on Insulet to $300 From $260

MT Newswires

9 days ago

BTIG Raises Price Target on Insulet to $270 From $260

MT Newswires

9 days ago

Bernstein Adjusts Price Target on Insulet to $305 From $300

MT Newswires

9 days ago

Stifel Adjusts Price Target on Insulet to $245 From $185

Insulet Corp (PODD) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions

GuruFocus.com

9 days ago

Insulet Corp (PODD) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions

Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

10 days ago

Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Insulet (PODD) Q3 Earnings and Revenues Top Estimates

Zacks

10 days ago

Insulet (PODD) Q3 Earnings and Revenues Top Estimates

MT Newswires

10 days ago

Insulet Q3 Adjusted Earnings, Revenue Rise, 2024 Revenue Outlook Raised

Associated Press Finance

10 days ago

Insulet: Q3 Earnings Snapshot

Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1)

Business Wire

10 days ago

Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1)

MT Newswires

11 days ago

Bernstein Starts Insulet With Outperform Rating, $300 Price Target

Argus Research

12 days ago

PODD: Raising target price to $253.00

Insulet Stock Gains From Expansion Strategies, Innovation

Zacks

13 days ago

Insulet Stock Gains From Expansion Strategies, Innovation

Stay Ahead of the Game With Insulet (PODD) Q3 Earnings: Wall Street's Insights on Key Metrics

Zacks

13 days ago

Stay Ahead of the Game With Insulet (PODD) Q3 Earnings: Wall Street's Insights on Key Metrics

Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November

Business Wire

16 days ago

Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November

Insulet (PODD) Earnings Expected to Grow: Should You Buy?

Zacks

17 days ago

Insulet (PODD) Earnings Expected to Grow: Should You Buy?

Insulet rolls out iPhone app for Omnipod 5 insulin pump in US

Medical Device Network

18 days ago

Insulet rolls out iPhone app for Omnipod 5 insulin pump in US

Omnipod® 5 App for iPhone® Now Fully Available in the United States

Business Wire

19 days ago

Omnipod® 5 App for iPhone® Now Fully Available in the United States

Here Is Why Analysts See More Growth After Meta's Impressive Gains

Investor's Business Daily

20 days ago

Here Is Why Analysts See More Growth After Meta's Impressive Gains

Is Insulet Stock a Smart Addition to Your Portfolio Right Now?

Zacks

25 days ago

Is Insulet Stock a Smart Addition to Your Portfolio Right Now?

PAHC vs. PODD: Which Stock Is the Better Value Option?

Zacks

a month ago

PAHC vs. PODD: Which Stock Is the Better Value Option?

Profitable S&P 500 Stocks to Buy in a Strong Q4: NVIDIA & 2 Others

Zacks

a month ago

Profitable S&P 500 Stocks to Buy in a Strong Q4: NVIDIA & 2 Others

Solventum Stock Earns 81 RS Rating

Investor's Business Daily

a month ago

Solventum Stock Earns 81 RS Rating

MT Newswires

a month ago

Leerink Adjusts Price Target on Insulet to $262 From $240

Insulet price target raised to $260 from $250 at BTIG

TipRanks

a month ago

Insulet price target raised to $260 from $250 at BTIG

MT Newswires

a month ago

BTIG Adjusts Price Target on Insulet to $260 From $250

Is Insulet Corporation (NASDAQ:PODD) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Insider Monkey

a month ago

Is Insulet Corporation (NASDAQ:PODD) The Top Stock With Improving Technical Ratings According To Piper Sandler?

We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)

Simply Wall St.

a month ago

We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)

National Campaign Launches to Combat Diabetes Stigma Using Comedy

PR Newswire

a month ago

National Campaign Launches to Combat Diabetes Stigma Using Comedy

Insulet Corp (PODD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance

GuruFocus.com

a month ago

Insulet Corp (PODD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance

MT Newswires

a month ago

Baird Adjusts Price Target on Insulet to $280 From $238, Maintains Outperform Rating

Here’s Why ClearBridge Growth Strategy Increased its Position in Insulet Corporation (PODD)

Insider Monkey

a month ago

Here’s Why ClearBridge Growth Strategy Increased its Position in Insulet Corporation (PODD)

Argus Research

a month ago

PODD: Lowering target price to $185.00

FMR LLC Bolsters Position in Insulet Corp with Strategic Share Acquisition

GuruFocus.com

a month ago

FMR LLC Bolsters Position in Insulet Corp with Strategic Share Acquisition

HLN or PODD: Which Is the Better Value Stock Right Now?

Zacks

a month ago

HLN or PODD: Which Is the Better Value Stock Right Now?

MT Newswires

2 months ago

Citigroup Adjusts Price Target on Insulet to $275 From $250, Maintains Buy Rating

Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size

Insider Monkey

2 months ago

Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size

Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024

Business Wire

2 months ago

Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024

Insulet's (NASDAQ:PODD) investors will be pleased with their respectable 48% return over the last five years

Simply Wall St.

2 months ago

Insulet's (NASDAQ:PODD) investors will be pleased with their respectable 48% return over the last five years

MT Newswires

2 months ago

Canaccord Genuity Adjusts Insulet Price Target to $269 From $236, Maintains Buy Rating

MT Newswires

2 months ago

Piper Sandler Adjusts Price Target on Insulet to $285 From $230, Maintains Overweight Rating

BAX vs. PODD: Which Stock Should Value Investors Buy Now?

Zacks

2 months ago

BAX vs. PODD: Which Stock Should Value Investors Buy Now?

A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

Simply Wall St.

2 months ago

A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)

MT Newswires

2 months ago

Insulet Insider Sold Shares Worth $1,718,283, According to a Recent SEC Filing

Insider Sale: Director Timothy Scannell Sells 5,000 Shares of Insulet Corp (PODD)

GuruFocus.com

2 months ago

Insider Sale: Director Timothy Scannell Sells 5,000 Shares of Insulet Corp (PODD)

MT Newswires

2 months ago

Insulet Insider Sold Shares Worth $1,129,200, According to a Recent SEC Filing

Insulet’s (PODD) Sales And Margins Surpassed Expectations

Insider Monkey

2 months ago

Insulet’s (PODD) Sales And Margins Surpassed Expectations

Morningstar Research

2 months ago

Analyst Report: Insulet Corporation

Should You Continue to Retain PODD Stock in Your Portfolio Now?

Zacks

2 months ago

Should You Continue to Retain PODD Stock in Your Portfolio Now?

Morningstar Research

3 months ago

Analyst Report: Insulet Corporation

Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching

Simply Wall St.

3 months ago

Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching

Why Insulet Stock Was Zooming Higher This Week

Motley Fool

3 months ago

Why Insulet Stock Was Zooming Higher This Week

Insider Sale at Insulet Corp (PODD): SVP & Chief Technology Officer Mark Field Sells Shares

GuruFocus.com

3 months ago

Insider Sale at Insulet Corp (PODD): SVP & Chief Technology Officer Mark Field Sells Shares

Argus Research

3 months ago

PODD: Raising target price to $202.00

S&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index

Investopedia

3 months ago

S&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index

MT Newswires

3 months ago

Sector Update: Health Care Stocks Edge Higher in Late Afternoon

MT Newswires

3 months ago

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

Top Stock Movers Now: Nvidia, Insulet, Paramount Global, and More

Investopedia

3 months ago

Top Stock Movers Now: Nvidia, Insulet, Paramount Global, and More

This Healthcare Stock Is the Best Performer in the S&P 500 After FDA Approval

Barrons.com

3 months ago

This Healthcare Stock Is the Best Performer in the S&P 500 After FDA Approval

Insulet's Omnipod 5 Wins FDA Approval for Type 2 Diabetes

Zacks

3 months ago

Insulet's Omnipod 5 Wins FDA Approval for Type 2 Diabetes

Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care

MedTech Dive

3 months ago

Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care

Insulet Omnipod cleared by FDA for type 2 diabetes

Medical Device Network

3 months ago

Insulet Omnipod cleared by FDA for type 2 diabetes

MT Newswires

3 months ago

Insulet Receives US FDA Clearance for Omnipod 5 in Adults with Type 2 Diabetes

Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes

Business Wire

3 months ago

Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes

Insulet expands Omnipod 5 pump to people with Type 2 diabetes

MedTech Dive

3 months ago

Insulet expands Omnipod 5 pump to people with Type 2 diabetes

Argus Research

3 months ago

PODD: Raising target price to $192.00

These Two Stocks Plunged After Eli Lilly Drug Study Showed Diabetes Promise

Investopedia

3 months ago

These Two Stocks Plunged After Eli Lilly Drug Study Showed Diabetes Promise

Insulet to Present at Upcoming Investor Conferences

Business Wire

3 months ago

Insulet to Present at Upcoming Investor Conferences

Insulet Corporation (PODD): This Diabetes Stock Is A Good Addition To Your Portfolio Now

Insider Monkey

3 months ago

Insulet Corporation (PODD): This Diabetes Stock Is A Good Addition To Your Portfolio Now

Insulet (NASDAQ:PODD) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Simply Wall St.

3 months ago

Insulet (NASDAQ:PODD) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

MT Newswires

3 months ago

Insulet Opens New Manufacturing Facility in Malaysia

Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia

Business Wire

3 months ago

Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia

Insulet Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

Insulet Second Quarter 2024 Earnings: Beats Expectations

Decoding Insulet Corp (PODD): A Strategic SWOT Insight

GuruFocus.com

3 months ago

Decoding Insulet Corp (PODD): A Strategic SWOT Insight

Morningstar Research

3 months ago

Analyst Report: Insulet Corporation

S&P 500 Gains and Losses Today: Expedia Soars as International Demand Drives Earnings Beat

Investopedia

3 months ago

S&P 500 Gains and Losses Today: Expedia Soars as International Demand Drives Earnings Beat

Insulin Pump Maker Insulet's Stock Slumps on User Growth Concerns

Investopedia

3 months ago

Insulin Pump Maker Insulet's Stock Slumps on User Growth Concerns

Insulet Is the Worst Stock in S&P 500 Today, Despite Solid Earnings. Here’s Why.

Barrons.com

3 months ago

Insulet Is the Worst Stock in S&P 500 Today, Despite Solid Earnings. Here’s Why.

Insulin Pump Maker Insulet's Growth Catalysts Set to Boost Revenue in 2025: Analyst

Benzinga

3 months ago

Insulin Pump Maker Insulet's Growth Catalysts Set to Boost Revenue in 2025: Analyst

MT Newswires

3 months ago

UBS Adjusts Insulet Price Target to $223 From $211, Maintains Neutral Rating

Insulet (PODD) Q2 Earnings Miss Estimates, '24 Sales View Raised

Zacks

3 months ago

Insulet (PODD) Q2 Earnings Miss Estimates, '24 Sales View Raised

MT Newswires

3 months ago

Canaccord Genuity Adjusts Price Target on Insulet to $236 From $234

MT Newswires

3 months ago

Wolfe Research Adjusts Price Target on Insulet to $220 From $205

Share on Social Networks: